AUTHOREA
Log in Sign Up Browse Preprints

loading page

Emergent data influences the risk/benefit assessment of hemophilia gene therapy using recombinant adeno-associated virus.
  • John Puetz
John Puetz

Corresponding Author:john.puetz@health.slu.edu

Author Profile